Sort   by:  
 Page size 

Background

The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown.

Methods

We randomly assigned patients with type 2 diabetes, with or without previous cardiovascular disease, to receive subcutaneous injecti...
Sort   by:  
 Page size